[go: up one dir, main page]

AU2001270678A1 - Vaccine against foot-and-mouth disease - Google Patents

Vaccine against foot-and-mouth disease

Info

Publication number
AU2001270678A1
AU2001270678A1 AU2001270678A AU7067801A AU2001270678A1 AU 2001270678 A1 AU2001270678 A1 AU 2001270678A1 AU 2001270678 A AU2001270678 A AU 2001270678A AU 7067801 A AU7067801 A AU 7067801A AU 2001270678 A1 AU2001270678 A1 AU 2001270678A1
Authority
AU
Australia
Prior art keywords
foot
vaccine against
mouth disease
against foot
mouth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270678A
Inventor
Jean-Christophe Audonnet
Alison Burman
Andrew King
Michel Lombard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Merial SAS
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial SAS, Merial Inc filed Critical Merial SAS
Publication of AU2001270678A1 publication Critical patent/AU2001270678A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A vaccine against foot-and-mouth disease, using as antigen an efficient amount of empty capsids of the foot-and-mouth virus. The empty capsids are obtained by expressing, in eukaryotic cells, cDNA of the P1 region of the foot-and-mouth virus genome coding for the capsid and cDNA of the region of the foot-and-mouth virus genome coding for protease 3C. The vaccine further includes a carrier or excipient pharmaceutically acceptable in veterinary medicine.
AU2001270678A 2000-06-29 2001-06-27 Vaccine against foot-and-mouth disease Abandoned AU2001270678A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0008437 2000-06-29
FR0008437A FR2810888B1 (en) 2000-06-29 2000-06-29 VACCINE AGAINST FOOT AND MOUTH DISEASE
PCT/FR2001/002042 WO2002000251A1 (en) 2000-06-29 2001-06-27 Vaccine against foot-and-mouth disease

Publications (1)

Publication Number Publication Date
AU2001270678A1 true AU2001270678A1 (en) 2002-01-08

Family

ID=8851899

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270678A Abandoned AU2001270678A1 (en) 2000-06-29 2001-06-27 Vaccine against foot-and-mouth disease

Country Status (13)

Country Link
US (1) US7531182B2 (en)
EP (1) EP1294400B1 (en)
JP (1) JP5153984B2 (en)
CN (1) CN1440296B (en)
AT (1) ATE552845T1 (en)
AU (1) AU2001270678A1 (en)
BR (1) BR0112071B1 (en)
CY (1) CY1116491T1 (en)
DK (1) DK1294400T3 (en)
ES (1) ES2386373T3 (en)
FR (1) FR2810888B1 (en)
PT (1) PT1294400E (en)
WO (1) WO2002000251A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2538486T3 (en) * 2002-09-12 2015-06-22 International Institute Of Cancer Immunology, Inc. Preparation of antigenic peptides against cancer
CN1320116C (en) * 2002-10-18 2007-06-06 中国人民解放军军需大学军事兽医研究所 O-type foot-and-mouth disease virus O _ NY00 strain genome sequence
CN100381170C (en) * 2003-09-03 2008-04-16 上海华谊生物技术有限公司 Foot and mouth disease bivalent polypeptide vaccine and its preparation method and use
CN1290579C (en) * 2003-10-15 2006-12-20 北京迪威华宇生物技术有限公司 Recombinant foot-and-mouth disease virus VP1 confluent protein vaccine
CN100342911C (en) * 2004-01-13 2007-10-17 厦门大学 Bivalent DNA vaccine of type A and type O foot-and-mouth disease virus and its preparing process
US7527960B2 (en) * 2004-06-25 2009-05-05 Merial Limited Avipox recombinants expressing foot and mouth disease virus genes
CA2592366C (en) * 2004-12-14 2013-11-19 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Recombinant foot and mouth disease vaccine
US9717788B2 (en) 2007-03-02 2017-08-01 Glaxosmithkline Biologicals Sa Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant
RU2631129C1 (en) * 2007-05-21 2017-09-19 Федеральное Казенное Предприятие "Щелковский Биокомбинат" Method for production of foot-and-mouth disease vaccine, and foot-and-mouth disease vaccine
CL2008001806A1 (en) * 2007-06-20 2008-09-05 Wyeth Corp COMPOSITION OF VACCINE IN EMULSION WATER IN OIL THAT INCLUDES AN ANTIGEN AND AN ADJUSTER IN THE WATERPROOF PHASE; AND METHOD OF ELABORATION.
CN101270155B (en) * 2008-05-06 2011-04-27 中国农业科学院兰州兽医研究所 Method for assembling empty capsids of foot-and-mouth disease virus in insects by acid-resistant modification
GB0918375D0 (en) 2009-10-20 2009-12-02 Animal Health Inst Construct
EP2494051B1 (en) * 2009-10-30 2016-03-09 Agresearch Limited Modified oil encapsulating proteins and uses thereof
US8974834B2 (en) 2010-01-15 2015-03-10 Ecolab Usa Inc. Method for producing reservoir layer for hoof treatment and reservoir layer
EP2545067B1 (en) * 2010-03-12 2016-11-30 Merial, Inc. Bluetongue virus recombinant vaccines and uses thereof
US8765141B2 (en) * 2010-07-01 2014-07-01 The United States Of America, As Represented By The Secretary Of Agriculture Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
CN101948811B (en) * 2010-08-18 2013-01-09 中国农业科学院兰州兽医研究所 Method for expanding antigen spectrum of foot-and-mouth disease vaccine strain by reverse genetic operation and preparation method of vaccine
GB201014965D0 (en) 2010-09-08 2010-10-20 Animal Health Inst Vaccine
US8906384B2 (en) * 2010-12-22 2014-12-09 The United States Of America As Represented By The Secretary Of Agriculture Antiviral activity of bovine type III interferon against foot-and-mouth disease virus
CN103060278B (en) * 2012-10-23 2014-07-09 于力 Asia 1 type foot and mouth disease virus acid resistant mutant strains, capsid protein carried by same and encoding gene thereof and application
RU2522868C1 (en) * 2013-03-06 2014-07-20 Федеральное государственное унитарное предприятие "Щелковский биокомбинат" Method of production of vaccine against foot-and-mouth disease
KR20210088754A (en) 2013-03-15 2021-07-14 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
NZ712410A (en) 2013-03-26 2020-01-31 The Pirbright Inst Stabilised fmdv capsids
KR101629353B1 (en) * 2013-06-20 2016-06-15 대한민국 Foot and mouth disease virus expressing P1-protective antigen of A type vaccine strain and the manufacturing method
KR101629345B1 (en) * 2013-06-26 2016-06-15 대한민국 Foot and mouth disease virus expressing P1-protective antigen of Asia1 type, IV genotype and the manufacturing method
KR101629282B1 (en) * 2013-06-26 2016-06-15 대한민국 Foot and mouth disease virus expressing P1-protective antigen of Asia1 type, V genotype and the manufacturing method
KR101578425B1 (en) 2013-07-26 2015-12-18 대한민국 Foot-and-mouth disease virus expressing P1-protective antigen of SAT1-WZ topotype and the manufacturing methods
RU2562547C1 (en) * 2014-04-16 2015-09-10 Федеральное государственное бюджетное учреждение "Федеральный центр охраны здоровья животных" (ФГБУ "ВНИИЗЖ") Inactivated sorptive foot-and-mouth disease type a vaccine
AP2017009834A0 (en) * 2014-09-23 2017-03-31 Merial Inc Fmdv recombinant vaccines and uses thereof
MA40920A (en) 2014-11-07 2017-09-12 Takeda Vaccines Inc VACCINES OF THE HAND, FOOT AND MOUTH, AND METHODS OF MANUFACTURING AND USE THEREOF
CN105505853B (en) * 2015-12-23 2019-03-15 中农威特生物科技股份有限公司 A low-serum medium for high-density suspension culture of BHK-21 cells and its application in the proliferation of foot-and-mouth disease virus
TWI760322B (en) 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 Recombinant adenovirus vectored fmdv vaccines and uses thereof
RU2617043C1 (en) * 2016-03-24 2017-04-19 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский и технологический институт биологической промышленности" (ФГБНУ ВНИТИБП) Vaccination against foot and mouth disease and method for its production and use
EP3675902A4 (en) * 2017-08-28 2021-06-23 Board of Trustees of Michigan State University COMPOSITIONS AND METHODS OF TREATMENT OF CANCER AND INFECTIONS USING BACTERIOPHAGE AND ITS MUTANTS
CN111744000B (en) * 2020-07-14 2021-03-23 中国农业科学院兰州兽医研究所 Foot-and-mouth disease recombinant virus with reduced immunosuppressive function and preparation method and application thereof
CN113817068B (en) * 2020-12-24 2024-01-30 北京微佰生物科技有限公司 O-type foot-and-mouth disease vaccine using human replication defective recombinant adenovirus as carrier
CN114957480B (en) * 2021-02-23 2024-01-30 北京微佰生物科技有限公司 A type foot-and-mouth disease vaccine using human replication defective recombinant adenovirus as carrier
KR20240046569A (en) 2021-08-20 2024-04-09 인터벳 인터내셔널 비.브이. Method for producing foot-and-mouth disease virus virus-like particles
WO2023020738A1 (en) 2021-08-20 2023-02-23 The Pirbright Institute Fmdv virus-like particle with double stabilizing mutation
CN117897170A (en) 2021-08-20 2024-04-16 英特维特国际股份有限公司 FMDV virus-like particles with stabilizing mutations
EP4387661A1 (en) 2021-08-20 2024-06-26 Intervet International B.V. Method of producing a foot and mouth disease virus virus-like particle
KR20240055683A (en) * 2022-10-19 2024-04-29 충남대학교산학협력단 Recombinant protein comprising protein derived from Foot and Mouth Disease virus type O capsid protein and swine Fc protein and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
ZA915593B (en) 1990-07-24 1993-03-31 Novagene Inc Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same
ZA934890B (en) * 1992-07-08 1994-04-14 Schering Corp Use of Gm-CSF as a vaccine adjuvant
CA2214029A1 (en) 1995-04-25 1996-10-31 Magda Marquet Single-vial formulations of dna/lipid complexes
DE19638044A1 (en) * 1996-09-18 1998-03-19 Bayer Ag Immunogenic peptides from foot-and-mouth disease viruses

Also Published As

Publication number Publication date
EP1294400A1 (en) 2003-03-26
US7531182B2 (en) 2009-05-12
EP1294400B1 (en) 2012-04-11
FR2810888A1 (en) 2002-01-04
US20040001864A1 (en) 2004-01-01
CN1440296B (en) 2012-04-11
CN1440296A (en) 2003-09-03
WO2002000251A1 (en) 2002-01-03
DK1294400T3 (en) 2012-07-23
FR2810888B1 (en) 2004-07-30
BR0112071B1 (en) 2014-08-26
ATE552845T1 (en) 2012-04-15
ES2386373T3 (en) 2012-08-20
WO2002000251A9 (en) 2002-04-04
JP5153984B2 (en) 2013-02-27
CY1116491T1 (en) 2017-03-15
BR0112071A (en) 2003-05-20
JP2004501874A (en) 2004-01-22
PT1294400E (en) 2012-07-10

Similar Documents

Publication Publication Date Title
AU2001270678A1 (en) Vaccine against foot-and-mouth disease
AP1872A (en) Virus-like particles of human papillomavirus.
Campo et al. Papillomavirus prophylactic vaccines: established successes, new approaches
AR022510A1 (en) FORMULATIONS OF VACCINES AGAINST HUMAN PAPILOMAVIRUS
LU91392I2 (en) "The viroid particle of the recombinant human papillomavirus L1 protein 16" - Cervarix
WO2001060847A3 (en) avirulent, immunogenic flavivirus chimeras
WO2003048184A3 (en) Flavivirus ns1 subunit vaccine
NO2013003I2 (en) Compounds as NS3 serine protease inhibitors for hepatitis C virus, pharmaceutical preparations and use of the compounds in the manufacture of a medicament
BG106417A (en) Vaccine
ZA200210230B (en) Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.
WO2002024897A3 (en) Conditionally replicating viral vectors and their use
AU2001275438A1 (en) Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
EP1420819A4 (en) SUBUNIT VACCINE FOR INFECTIOUS PANCREATIC NECROSIS VIRUS
WO2002078631A3 (en) Improved conditionally replicating vectors for inhibiting viral infections
CO5261595A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF SALMETEROL AND IPRATROPIUM
MXPA02003328A (en) Vaccine.
MXPA02012593A (en) Bvdv virus-like particles.
MXPA01005808A (en) Ibdv strain for in ovo administration.
AU5460900A (en) Infectious cdna clone of gb virus b and uses thereof
CA2295316A1 (en) Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy
TW200509964A (en) VP1 of foot-and-mouth disease virus
MX2007013472A (en) Vaccine.
UA95299C2 (en) Prophylactic or therapeutic agent for viral disease caused by hepatitis c virus
CA2363493A1 (en) Attenuated forms of bovine viral diarrhea virus
PT1194450E (en) INACTIVATED VACCINE AGAINST FELINE CALCIVIROSIS